EBV DNA quantitative
Allows the determination of the amount of genetic material of Epstein-Barr virus (EBV)

Synevo
- Test description
- Documents
EBV DNA quantitative.
Clinical use
Diagnosis of Epstein-Barr Virus (EBV; human herpesvirus 4, HHV-4), diagnosis of infectious mononucleosis.
Patient Preparation
Material: Serum
Interventions
The basis of detecting genetic changes by molecular biology methods is the amplification of the patient's genetic material by polymerase chain reaction (PCR). Note that someóre drugs inhibit the PCR reaction, making it difficult or impossible to perform the test. These drugsów include someóre anticoagulants (such as heparin) and antiviral drugs (such as acyclovir). If the patient is taking drugs that inhibit PCR or preparations with unknown effects on PCR, blood should be drawn when the plasma concentrations of these drugsóre relatively lowest, such as just before the next dose. Drugs taken by the patient with potential inhibitory effects on PCR should be noted on the referral form. If in doubt, contact the Laboratory